ResearcherFred Hutch Cancer CenterActive in the last 2 years
Naomi Yamamoto
Matched on ORCID iD 0000-0002-0641-6547; OpenAlex author ID A5034744861. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 27
2025: 2 papers · 2026: 3 papers
Papers 5
- ZNF274 constrains lineage plasticity and drives intrinsic resistance to CDK7 inhibitors in pancreatic cancer. Co-author DOI 10.1038/s41467-026-73380-x↗
- Phase 2 study of azacitidine plus pembrolizumab as second-line treatment in patients with locally advanced or metastatic pancreatic ductal adenocarcinoma. Co-author DOI 10.1093/oncolo/oyag091↗
- HMGA2 Expression in Pancreatic Ductal Adenocarcinoma Controls Tumor Microenvironment and Immunosuppression via IL1α Co-author DOI 10.64898/2026.10.02.754697↗
- HMGA2 and protein leucine methylation drive pancreatic cancer lineage plasticity. First author DOI 10.1038/s41467-025-60129-1↗
- HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-24-2200↗
Closest collaborators
The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Sita Kugel · 5 shared papers, 2025–2026 · strength 1.09
- Paper Phase 2 study of azacitidine plus pembrolizumab as second-line treatment in patients with locally advanced or metastati… DOI 10.1093/oncolo/oyag091↗
- Paper ZNF274 constrains lineage plasticity and drives intrinsic resistance to CDK7 inhibitors in pancreatic cancer. DOI 10.1038/s41467-026-73380-x↗
- Paper HMGA2 Expression in Pancreatic Ductal Adenocarcinoma Controls Tumor Microenvironment and Immunosuppression via IL1α DOI 10.64898/2026.10.02.754697↗
- Stephanie Dobersch · 4 shared papers, 2025–2026 · strength 0.83
- Paper ZNF274 constrains lineage plasticity and drives intrinsic resistance to CDK7 inhibitors in pancreatic cancer. DOI 10.1038/s41467-026-73380-x↗
- Paper HMGA2 Expression in Pancreatic Ductal Adenocarcinoma Controls Tumor Microenvironment and Immunosuppression via IL1α DOI 10.64898/2026.10.02.754697↗
- Paper HMGA2 and protein leucine methylation drive pancreatic cancer lineage plasticity. DOI 10.1038/s41467-025-60129-1↗
- Faiyaz Notta · 4 shared papers, 2025–2026 · strength 0.83
- Paper ZNF274 constrains lineage plasticity and drives intrinsic resistance to CDK7 inhibitors in pancreatic cancer. DOI 10.1038/s41467-026-73380-x↗
- Paper HMGA2 Expression in Pancreatic Ductal Adenocarcinoma Controls Tumor Microenvironment and Immunosuppression via IL1α DOI 10.64898/2026.10.02.754697↗
- Paper HMGA2 and protein leucine methylation drive pancreatic cancer lineage plasticity. DOI 10.1038/s41467-025-60129-1↗
- Rachael Ann Safyan · 2 shared papers, 2025–2026 · strength 0.45
- Adrianne Wallace-Povirk · 2 shared papers, 2026 · strength 0.45
- Paper ZNF274 constrains lineage plasticity and drives intrinsic resistance to CDK7 inhibitors in pancreatic cancer. DOI 10.1038/s41467-026-73380-x↗
- Paper HMGA2 Expression in Pancreatic Ductal Adenocarcinoma Controls Tumor Microenvironment and Immunosuppression via IL1α DOI 10.64898/2026.10.02.754697↗
- Nina G. Steele · 2 shared papers, 2025–2026 · strength 0.41
- Ian M. Loveless · 2 shared papers, 2025–2026 · strength 0.41
- Sunil R. Hingorani · 2 shared papers, 2025–2026 · strength 0.41
- Howard C. Crawford · 2 shared papers, 2025–2026 · strength 0.41
- Susan Elaine Bates · 1 shared paper, 2026 · strength 0.26
- Ruth Aroon White · 1 shared paper, 2026 · strength 0.26
- Jacob K.R. Jamison · 1 shared paper, 2026 · strength 0.26
- Tamas A. Gonda · 1 shared paper, 2026 · strength 0.26
- Gulam Abbas Manji · 1 shared paper, 2026 · strength 0.26
- Paul E. Oberstein · 1 shared paper, 2026 · strength 0.26
- Sabrina Ge · 1 shared paper, 2026 · strength 0.23
- Jessica E. Gianopulos · 1 shared paper, 2026 · strength 0.23
- Debora Barbosa Vendramini Costa · 1 shared paper, 2026 · strength 0.22
- Ralph A. Francescone III · 1 shared paper, 2026 · strength 0.22
- Joana E. Aggrey-Fynn · 1 shared paper, 2026 · strength 0.22
- Gregory Lawrence Beatty · 1 shared paper, 2026 · strength 0.22
- Srivatsan Raghavan · 1 shared paper, 2025 · strength 0.19
- Liang‐I Kang · 1 shared paper, 2025 · strength 0.19
- Nathan M. Bolton · 1 shared paper, 2025 · strength 0.19
- Ryan C Fields · 1 shared paper, 2025 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.